University of Barcelona Study Shows Pemafibrate and Telmisartan Reduce Liver Fat in Animal Models of Fatty Liver Disease
A new study from the University of Barcelona shows that combining two existing drugs—pemafibrate and telmisartan—can significantly reduce liver fat in animal models of fatty liver disease. How the drug combination works in preclinical models Researchers led by Professor Marta Alegret tested pemafibrate, which lowers blood fat and telmisartan, a blood pressure medication, on rats … Weiterlesen …